myeloma

In the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T therapy for multiple…

Panama7/iStock Editorial via Getty Images Sanofi (NASDAQ:SNY) said the FDA has accepted for priority review the supplemental Biologics License Application…